Plant with flowers, for article on Sumerian medicinal plants

Ancient Sumerians record hundreds of medicinal plants on clay tablets

Somewhere in ancient Mesopotamia, a scribe pressed a stylus into wet clay and recorded something remarkable: a working list of medicinal plants, organized and preserved for others to use. That act — modest in itself — helped launch one of humanity’s oldest ongoing projects: the systematic understanding of how the natural world can heal.

What the evidence shows

  • Sumerian medicinal plants: Clay tablets from ancient Mesopotamia record hundreds of plant-based remedies, including myrrh and opium — among the earliest written pharmacological records in human history.
  • Written herbalism: The Sumerian tablets mark the transition from oral and experiential plant knowledge to documented, transmissible medical information — a shift that shaped every healing tradition that followed.
  • Ancient plant medicine: The Sumerian record is part of a broader pattern: parallel traditions in Egypt, India, and China were building similarly sophisticated herbal systems at roughly the same historical moment.

Before anyone wrote it down

The use of plants as medicine is far older than writing. Hominids other than Homo sapiens — including orangutans — have been observed treating injuries and illness with medicinal plants. Neanderthal burial sites suggest that our closest evolutionary relatives were using plant-based remedies as far back as 60,000 years ago.

Ötzi the Iceman, whose body was preserved in the Alps for more than 5,000 years, carried herbs in his personal effects that appear to have been used to treat intestinal parasites. The knowledge was there long before anyone found a way to write it down.

What the Sumerians did was different. They created a record — a transmissible document that could outlast any single practitioner, teacher, or generation.

A civilization that took knowledge seriously

The Sumerians of ancient Mesopotamia — in what is now southern Iraq — are credited with some of the earliest writing systems in human history. Their clay tablets covered trade, law, astronomy, and literature. That they also catalogued medicinal plants reflects something important: they understood that knowledge, organized and preserved, has compounding value over time.

The tablets listed hundreds of plants. Among them were myrrh, used across the ancient world as an antiseptic and anti-inflammatory, and opium, whose pain-relieving properties would anchor medicine for millennia. These were not speculative entries. They reflected generations of accumulated empirical observation — what worked, what didn’t, and in what quantities.

Mesopotamia’s position between rivers, trade routes, and neighboring cultures also meant that Sumerian herbalists likely had access to plant knowledge from beyond their immediate region. The tablets were as much a record of exchange as of invention.

A world of parallel breakthroughs

The Sumerian effort was not happening in isolation. In ancient Egypt, healers were compiling what would eventually become the Papyrus Ebers — a document listing more than 850 plant medicines, including garlic, cannabis, aloe, and castor bean. In India, early Ayurvedic traditions were building a system that would eventually be codified in texts like the Sushruta Samhita, describing 700 medicinal plants. In China, legendary emperor Shennong was credited with cataloguing 365 medicinal plants, a text that introduced ephedra — and eventually the drug ephedrine — to the world.

These traditions were largely independent. That they converged on similar methods — observation, documentation, categorization — speaks to something universal in how humans process and share practical knowledge.

Lasting impact

The Sumerian tablets helped establish the basic architecture of pharmacology: the idea that specific plants, used in specific ways, could produce predictable outcomes. That architecture never went away.

Many compounds first noted in ancient herbal traditions became the basis for modern pharmaceuticals. Opium gave rise to morphine, codeine, and an entire class of pain management drugs. Compounds from plants in traditional Chinese, Indian, and Mesoamerican medicine have informed treatments for malaria, heart disease, and cancer. The World Health Organization estimates that roughly 80% of the global population still uses plant-based medicine as a primary or supplementary form of health care.

The Sumerians did not know what would follow. They were solving an immediate problem: how do you make sure the next healer knows what this generation learned? Their answer — write it down — turned out to be one of the most consequential decisions in the history of medicine.

The pharmaceutical industry, the modern hospital formulary, and the herbal supplement on a pharmacy shelf all trace a line back to that impulse.

Blindspots and limits

The surviving record is fragmentary. Most of what Sumerian healers knew, believed, or practiced is gone — lost to time, incomplete excavation, or tablets that never survived. The line between medical knowledge and ritual or spiritual practice in ancient Mesopotamia was also not as clean as modern framing suggests; healers were often priests, and treatments combined plant remedies with incantations in ways the tablets may not fully capture.

It is also worth being precise: the tablets recorded plant names and uses, but the scientific mechanisms behind those uses — why myrrh inhibits bacterial growth, or why opium suppresses pain — were entirely unknown. The knowledge was real. The explanatory framework was not yet there. That distinction matters when tracing the long road from ancient herbalism to evidence-based medicine.

What it means to write something down

There is a version of this story that focuses on Sumerian civilization as a singular achievement. But the more accurate — and more moving — story is that humans everywhere, across thousands of years and dozens of unconnected cultures, arrived at the same conclusion: the plants around us can heal, and that knowledge is too important to lose.

The Sumerians gave that conclusion a durable form. They pressed it into clay, fired it, and let it survive. The World Health Organization’s ongoing work on traditional medicine reflects how seriously that inheritance is still taken. So does the Royal Botanic Gardens Kew’s Medicinal Plant Names Services, which today catalogs and preserves plant knowledge from cultures around the world — a digital descendant, in a sense, of what those ancient scribes began.

Every time a researcher screens a plant compound for pharmaceutical potential, they are doing something the Sumerians would have recognized: looking carefully at the natural world and asking what it has to offer. The National Institutes of Health’s research on plant-derived medicines has helped confirm that at least 25% of modern drugs have origins in plant compounds identified through traditional knowledge systems. And the ethno-pharmacology research published in journals like Science continues to draw on Indigenous and traditional plant knowledge as a starting point for drug discovery.

The clay tablets are gone from active use. The knowledge they carried is not.

Read more

For more on this story, see: Wikipedia — History of Herbalism

For more from Good News for Humankind, see:

About this article

  • 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
  • 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
  • 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
  • ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.

More Good News

  • Rows of solar panels in a Chinese desert reflecting China wind and solar capacity growth under the Five-Year Plan clean energy targets

    China plans to double its already massive clean energy supply by 2035

    China’s new climate pledge to the United Nations sets a target of 3,600 gigawatts of wind and solar power by 2035 — more than the entire electricity-generating capacity of the United States today, and roughly double what China has already built. The commitment is woven into the country’s next Five-Year Plan, which directs state banks, provinces, and manufacturers to move in the same direction. Because China makes about 80% of the world’s solar panels, every factory it scales up makes clean energy cheaper for buyers in Africa, Southeast Asia, Latin America, and everywhere else. That ripple effect is what makes…


  • Medical researcher in a lab examining vials related to asthma and COPD treatment and mRNA vaccine development, for article on benralizumab injection

    Doctors hail first breakthrough in asthma and COPD treatment in 50 years

    Benralizumab, a single injection given during an asthma or COPD attack, outperformed the steroid pills that have been the only emergency option since the 1970s. In a King’s College London trial of 158 patients, those who got the shot had four times fewer treatment failures over 90 days, along with easier breathing and fewer follow-up visits. Because steroids carry real risks with repeated use — diabetes, osteoporosis, and more — a genuine alternative could change daily life for millions of people who live in fear of the next flare-up. After a half-century of stalled progress on diseases that claim 3.8…


  • A nurse in a rural Mexican clinic checks a patient's blood pressure, for an article about Mexico universal healthcare

    Mexico launches universal healthcare for all 133 million citizens

    Mexico universal healthcare is now officially a reality, with the country launching a system designed to cover all 133 million citizens through the restructured IMSS-Bienestar network. Before this reform, an estimated 50 million Mexicans had no formal health insurance, with rural and Indigenous communities bearing the heaviest burden of untreated illness and medical debt. The new system severs the long-standing tie between employment and healthcare access, providing free consultations, medicines, and hospital services regardless of income. If implemented effectively, Mexico’s move could serve as a powerful model for other middle-income nations still navigating fragmented, inequitable health systems.



Coach, writer, and recovering hustle hero. I help purpose-driven humans do good in the world in dark times - without the burnout.